Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Warrants

v3.21.1
Stock-Based Compensation and Warrants
3 Months Ended
Mar. 31, 2021
Stock-Based Compensation and Warrants  
Stock-Based Compensation and Warrants

Note 12 – Stock-Based Compensation and Warrants

As of March 31, 2021, the Company had 704,668 remaining shares available for issuance under the 2019 Equity Incentive Plan (“2019 Equity Plan”).

Stock-based compensation cost for the three months ended March 31, 2021 and 2020 was $1.0 million and $0.3 million, respectively. Stock-based compensation is included in general and administrative expenses in the condensed consolidated statements of operations and comprehensive income (loss). Included in stock-based compensation cost was $0.1 million and $0.1 million of stock granted to directors for the three months ended March 31, 2021 and 2020, respectively. Such grants were awarded consistent with the Board of Director’s compensation practices. In addition, stock-based compensation expense for the three months ended March 31, 2021 includes $0.3 million of compensation costs for the vesting of market condition based options and RSUs.

Stock Option Activity

Stock options in the table below includes both time based and market condition based awards. Changes in stock options during the three months ended March 31, 2021 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

average

 

Intrinsic

 

 

 

 

average exercise

 

remaining

 

value

 

    

Shares

    

price

    

contractual life

    

(thousands)

Outstanding at December 31, 2020

 

2,286,410

 

$

3.29

 

4.97 years

 

$

1,879

Exercisable at December 31, 2020

 

1,443,675

 

$

3.57

 

4.68 years

 

$

1,112

Granted

 

 —

 

 

 —

 

  

 

 

  

Exercised

 

 —

 

 

 —

 

  

 

 

  

Cancelled, expired or forfeited

 

 —

 

 

 —

 

  

 

 

  

Outstanding at March 31, 2021

 

2,286,410

 

$

3.29

 

4.72 years

 

$

9,590

Exercisable at March 31, 2021

 

2,045,743

 

$

3.41

 

4.54 years

 

$

8,323

 

A summary of the status of the Company’s non-vested stock options as of December 31, 2020 and March 31, 2021 and changes during the three months then ended, is presented below:

 

 

 

 

 

 

 

 

 

 

 

Weighted average

 

    

Shares

    

grant date fair value

Non-vested stock options at December 31, 2020

 

263,333

 

$

0.99

Vested

 

(22,667)

 

 

1.55

Non-vested stock options at March 31, 2021

 

240,666

 

$

0.94

 

The fair value of options that vested in the three months ended March 31, 2021 was less than $0.1 million. As of March 31, 2021, there is $0.1 million of total unrecognized compensation cost related to non-vested awards, which will be recognized over a weighted-average period of 1.4 years.

Restricted Stock Unit Activity

The Company issues restricted stock units (“RSUs”) under the 2019 Equity Plan. The fair value of these RSUs is determined based upon the closing fair market value of the Company’s common stock on the grant date.

A summary of the status of RSUs and changes during the three months ended March 31, 2021 is presented below:

 

 

 

 

 

 

 

 

 

 

 

Weighted average

 

    

Shares

    

grant date fair value

Non-vested RSUs at December 31, 2020

 

1,871,592

 

$

1.68

Granted

 

421,381

 

 

5.09

Vested

 

(910,540)

 

 

1.75

Cancelled, expired or forfeited

 

(12,000)

 

 

2.50

Non-vested RSUs at March 31, 2021

 

1,370,433

 

$

2.73

 

As of March 31, 2021, the Company had approximately $3.2 million of total unrecognized compensation costs related to RSUs, which will be recognized over a weighted average period of 2.4 years.

Warrants

As of December 31, 2020, there were 865,000 warrants available to be exercised at exercise prices ranging from $1.63 to $2.61. During the first quarter of 2021, the Company issued 450,971 shares in connection with the cashless exercise by Anson Investments Master Fund LP of 640,000 warrants. As of March 31, 2021, there were 225,000 warrants available to be exercised. In April 2021, the Company issued 100,000 shares to 22235570 Ontario Limited in connection with its exercise of a warrant for aggregate consideration of $261,000.